Carcell BioPharma

Carcell Biopharma is a pre-clinical biotechnology company focused on the development of innovative cell and gene therapy products. The company specializes in engineered red blood cells aimed at immune regulation and employs non-viral vector gene delivery systems based on lipid nanoparticles. By utilizing a unique cross-border business model, Carcell Biopharma is dedicated to accelerating the discovery and development of next-generation therapies, positioning itself at the forefront of biopharmaceutical advancements.